Product name:Citicoline sodium
CAS:33818-15-4
Molecular Formula:C14H25N4NaO11P2
Formula Weight:510.31
Specification:100mg
Description:
Citicoline is a nucleic acid derivative. In 1956, Geiger found in animal experiments that citicoline could restore brain injury. Kennedy's 1957 study confirmed its critical role in the synthesis of lecithin, which was developed by takeda pharmaceutical in 1961 and registered in China in 1988. It is the best selling drug in clinical treatment of brain diseases, plays an important role in the synthesis of lecithin, and improves brain function by promoting the synthesis of lecithin. Experimental results show that citicoline can enhance the central nervous system of norepinephrine and dopamine levels, thereby treating cerebrovascular disease, brain trauma and various causes of cognitive impairment, and no obvious side effects.
Citicoline sodium can enhance brain stem reticular structure, especially the function of ascending reticular structure activation system closely related to consciousness, enhance the role of pyramidal system, inhibit the role of extrapyramidal system, and promote awakening. At the same time, it can reduce cerebral vascular resistance, increase cerebral blood perfusion and promote cerebral metabolism. It is mainly used to treat sequelae of the nervous system caused by craniocerebral injury and cerebrovascular accident. For the treatment of cerebrovascular and cardiovascular diseases; Others, such as delaying aging, improving learning and memory, are also effective.